Medico — August 2024
-
forside
nyhederGN-topchef: Vi fokuserer på alt det vi selv kan kontrollere https://proinvestor.com/investornyt/1203565/gn-topchef-vi-fokuserer-pa-alt-det-vi-selv-kan-kontrollere
-
Demants anbefaling løftes til neutralt territorium hos Jefferies https://proinvestor.com/investornyt/1204080/demants-anbefaling-loftes-til-neutralt-territorium-hos-jefferies
-
GN får tage toppen af kursmål hos DNB https://proinvestor.com/investornyt/1204078/gn-far-tage-toppen-af-kursmal-hos-dnb
-
GN's kursmål skåret knap 6 pct. af Carnegie https://proinvestor.com/investornyt/1204079/gns-kursmal-skaret-knap-6-pct-af-carnegie
-
GN's kursmål reduceres af Morgan Stanley https://proinvestor.com/investornyt/1204076/gns-kursmal-reduceres-af-morgan-stanley
-
Novonesis sænkes til "hold" hos Carnegie https://proinvestor.com/investornyt/1205004/novonesis-saenkes-til-hold-hos-carnegie
-
Novonesis increases its full-year sales and profitability outlook based on the first half year performance coupled with strong momentum going into the first months of the second half.
The 2024 outlook is increased to:
• Pro forma organic sales growth of now 7-8% (previously “upper end of 5-7%”)
• Pro forma adjusted EBITDA margin of now 35.5-36.5% (previously “35-36%”)
Additional information is made available in the Company announcement: Interim Report H1 2024.
-
Novonesis vil udbetale udbytte på 2 kr. per aktie https://proinvestor.com/investornyt/1205769/novonesis-vil-udbetale-udbytte-pa-2-kr-per-aktie
-
Novonesis leverer tocifret vækst i andet kvartal og opjusterer forventningerne https://proinvestor.com/investornyt/1205783/novonesis-leverer-tocifret-vaekst-i-andet-kvartal-og-opjusterer-forventningerne
-
Novonesis leverer solidt drift: Men grænset potentiale efter årets stigninger vurderer storbank https://proinvestor.com/investornyt/1206013/novonesis-leverer-solidt-drift-men-graenset-potentiale-efter-arets-stigninger-vurderer-storbank
-
Novonesis får løftet kursmålet hos Danske Bank: Ser stærkt vækstmomentum lige nu https://proinvestor.com/investornyt/1206670/novonesis-far-loftet-kursmalet-hos-danske-bank-ser-staerkt-vaekstmomentum-lige-nu
-
GN får pillet en tyver af kursmålet til 225 kr. hos Jefferies https://proinvestor.com/investornyt/1207170/gn-far-pillet-en-tyver-af-kursmalet-til-225-kr-hos-jefferies
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind